Neural tube defects and 19 bp deletion within intron-1 of dihydrofolate reductase gene

Turkish Journal of Medical Sciences

Volumn 38, Issue 5, 2008, Pages 383-386

  Akar, Nejat ^a,b   Akar, Ece ^a   Eǧin, Yonca ^a   Deda, Gülhis ^a   Arsan, Saadet ^a   Ekim, Mesiha ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Dihydrofolate reductase; Neural tube defects; Spina bifida

Indexed keywords

BIOCHEMISTRY; METALLIC MATRIX COMPOSITES; TUBES (COMPONENTS);

CASE-CONTROL STUDY; DIHYDROFOLATE REDUCTASE; DIHYDROFOLATE REDUCTASE GENE; FOLATES; NEURAL TUBE DEFECTS; ODDS RATIOS; SPINA BIFIDA; TURKISH;

SEMICONDUCTOR DOPING;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIHYDROFOLATE REDUCTASE GENE; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; HOMOZYGOSITY; HUMAN; HUMAN GENOME; INTRON; MAJOR CLINICAL STUDY; MENINGOMYELOCELE; MOTHER; NEURAL TUBE DEFECT; NEWBORN; SPINA BIFIDA; TURKEY (REPUBLIC);

EID: 54749123182     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Campbell LR, Dayton DH, Sohal GS. Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 1986; 34: 171-8.
2. Akar N, Çavdar AO, Arcasoy A. High incidence of neural tube defect in Bursa, Turkey. Paediatric Perinat Epid 1988; 2: 89-92.
3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
4. Akar N, Akar E, Deda G, Arsan S. Spina bifida and common mutations at the homocysteine metabolism pathway. Clin Genet 2000; 57: 230-1.
5. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 677 CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey. Arch Dis Child 1998; 78: 235.
6. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJJM, Finkelstein JJD, Blom HJ, Thomas CMG. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 1994; 43: 1475-80.
7. Smithells RW, Sheppard S. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980; 1: 647.
8. Wild J, Read AP, Sheppard S, Seller MJ, Smithells RW, Nevin NC. Recurrent neural tube defects, risk factors and vitamins. Archs Dis Child 1986; 61: 440-4.
9. Anderson AC. Targeting DHFR in parasitic protozoa. Drug Discovery Today 2005; 10(2): 121-8.
10. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet 2004; 124A(4): 339-45.
11. Van der Linden IJ, Nguyen U, Heil SG, Franke B, Vloet S, Gellekink H et al. Variation and expression of dihydrofolate reductase in relation to spina bifida. Mol Genet Metab 2007; 91(1): 98-103.
12. Parle-McDermott A, Pangilinan F, Mills JL, Kirke PN, Gibney ER, Troendle J. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet A 2007; 143(11): 1174-80. 387-397